Skip to main content
. 2021 Oct 30;10(21):5101. doi: 10.3390/jcm10215101

Table 4.

Clinical outcomes during the whole follow-up in the unmatched cohort of patients with AF and prevalent or incident HF with follow-up starting at the time of last event between AF or HF.

Prevalent HF
(n = 956,086)
Incident HF (n = 393,552) HR (95% CI) for
Prevalent HF
vs. Incident HF
p (Uncorrected) p (Bonferroni Correction)
All-cause death 316,729 (19.0) 126,688 (21.8) 0.91 (0.91–0.92) <0.0001 <0.0001
Cardiovascular death 117,294 (7.1) 41,431 (7.1) 1.04 (1.03–1.06) * <0.0001 <0.0001
Non-cardiovascular death 199,435 (12.0) 85,257 (14.7) 0.85 (0.84–0.86) <0.0001 <0.0001
Ischemic stroke 40,670 (2.5) 14,266 (2.6) 0.97 (0.95–0.99) 0.006 0.02
Re-hospitalization for HF 254,885 (19.3) 45,877 (13.8) 1.43 (1.42–1.45) <0.0001 <0.0001
Cancer 73,528 (4.7) 25,214 (4.9) 0.96 (0.94–0.97) <0.0001 <0.0001

* hazard ratio = 1.10 (1.08–1.11), uncorrected p < 0.0001, corrected p < 0.0001 by Fine and Gray model for competing risks of cardiovascular and non-cardiovascular death. hazard ratio = 1.04 (1.02–1.06), uncorrected p < 0.0001, corrected p < 0.0001 by Fine and Gray model for competing risks of ischemic stroke and death. Values are n (incidence rate, %/year). AF, atrial fibrillation; CI, confidence interval; HF, heart failure; HR, hazard ratio.